Biden warns U.S. won’t have enough Covid vaccine shots this fall if Congress fails to pass funding

Biden warns U.S. won’t have enough Covid vaccine shots this fall if Congress fails to pass funding


U.S. President Joe Biden receives a second coranavirus disease (COVID-19) booster vaccination after delivering remarks on COVID-19 in the Eisenhower Executive Office Building’s South Court Auditorium at the White House in Washington, U.S., March 30, 2022. 

Kevin Lamarque | Reuters

President Joe Biden warned Wednesday that the U.S. will not have enough Covid vaccine shots this fall to ensure free and easy access for all Americans if Congress fails to pass the $22.5 billion in additional funding the administration has requested.

Biden said the U.S. has enough supply to ensure people eligible for fourth shots have access to them. The Centers for Disease Control and Prevention this week recommended an additional Pfizer or Moderna dose for people ages 50 and older, as well as certain younger individuals who have compromised immune systems.

Biden, 79, received his fourth dose on live television after his remarks.

As the country enters a new phase of its vaccination push, the president called on Congress to act to ensure the U.S. has the resources it needs if another wave of infection emerges.

“Americans are back to living their lives again,” Biden said. “We can’t surrender that. Congress please act. You have to act immediately. The consequences of inaction are severe, they will only grow with time.”

New infections and hospitalizations have plummeted more than 90% from the peak of the winter omicron wave in January. However, the decline of infections has slowed and plateaued in recent days as a more contagious omicron subvariant, BA.2, has become the dominant version of Covid in the U.S. BA.2 has already caused new waves of infection in Europe and China.

White House chief medical advisor Dr. Anthony Fauci said earlier this month that BA.2 will likely cause infections to rise in the U.S. He does not expect another surge in cases.

The Institute for Health Metrics and Evaluation in Washington state is projecting that infections will continue to fall through the spring and summer. However, Ali Mokdad, an epidemiologist at IHME, said another surge could happen in the fall as immunity from the vaccines wanes and people move inside during the colder weather.

Democrats and Republicans in Congress have failed to reach a bipartisan agreement on $15 billion in Covid funding, a sum lower than the White House request. Republicans want to cover any new spending by cutting funds already appropriated for state and local governments. Democrats rejected that demand.

Negotiations are ongoing in the House and Senate to find a compromise.

Biden also warned the U.S. will not have the money to surge testing, monoclonal antibody treatments and antiviral pills if another Covid wave sweeps the U.S.

The president also unveiled a new government website, covid.gov, where Americans can find out where they can obtain masks, tests, vaccines and treatments.

CNBC Health & Science

Read CNBC’s latest global coverage of the Covid pandemic:



Source

Moderna cuts high end of 2025 revenue outlook on vaccine shipment delay in U.K.
Health

Moderna cuts high end of 2025 revenue outlook on vaccine shipment delay in U.K.

Moderna logo is seen in Warsaw, Poland on April 9, 2025. Jakub Porzycki | Nurphoto | Getty Images Moderna on Friday lowered the high end of its 2025 revenue outlook due to a delay in vaccine shipments to the U.K., but beat Wall Street’s expectations for the second quarter as it works to cut costs. […]

Read More
Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days
Health

Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days

U.S. President Donald Trump, U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr., Dr. Mehmet Oz, Administrator for the Centers for Medicare & Medicaid Services, David Sacks, AI & Crypto Czar and Amy Gleason, Acting Administrator, Department of Government Efficiency (DOGE) attend the “Making Health Technology Great Again” event in the East Room […]

Read More
Eli Lilly’s Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity
Health

Eli Lilly’s Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity

Mounjaro manufactured by Eli Lilly and Company packaging is seen in this illustration photo taken in a pharmacy in Krakow, Poland on April 9, 2024. Nurphoto | Nurphoto | Getty Images Eli Lilly on Thursday said its blockbuster diabetes drug Mounjaro showed heart health benefits in a late-stage trial directly comparing it to the company’s […]

Read More